Russia approves rules for launch of new drugs in domestic market

Leading Russian and foreign drugmakers operating in Russia will be able to launch their drugs more quickly in the local pharmaceutical market, thanks to the recent amendments approved by the Council of Federation, the upper house of the Russian Parliament, reports The Pharma Letter’s local correspondent.

Under current legislation, the launch of a new drug into the local market is only possible after the completion a procedure of its mandatory certification. Such registration has usually been conducted in specially accredited centers and always led to significant time losses and additional costs for producers.

However, the adoption of the new amendments will help to significantly speed this process, and to lift the existing certification procedure.